Clinical Trial Update: Onabotulinumtoxin A and Hyaluronic Acid Fillers in the Treatment of Facial Paralysis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating onabotulinumtoxin A and hyaluronic acid fillers for hemifacial paralysis is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemifacial Paralysis

Drugs mentioned

• Hyaluronic acid fillers (hyaluronic acid fillers)
• Onabotulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: Azienda Ospedaliera Universitaria Integrata Verona | Conditions: Hemifacial Paralysis | Phase 2 | Status: UNKNOWN